DANIEL J. STARKS - 29 Apr 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
29 Apr 2022
Transactions value $
$0
Form type
4
Filing time
03 May 2022, 18:23:35 UTC
Next filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Award $0 +1.6K +0.02% $0.00 7.02M 29 Apr 2022 Direct F1
holding ABT Common shares without par value 258 29 Apr 2022 Alynne Starks 2012 Irrevocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.